-
Kenya's economy faces climate change risks: World Bank
-
Defiant Orban digs in over blocked Ukraine loan at EU talks
-
Tokyo's dazzling cherry blossom season officially begins
-
Energy prices surge, stocks sink amid rising energy shock fears
-
Baby monkey Punch acclimatising, making new friends at Japan zoo
-
Labubu creators hope for monster film hit in Sony co-production
-
Patching the wounds of Kinshasa's street children
-
Strait of Hormuz blockage drives up Gulf food bills
-
Mideast energy shock rattles eurozone rate-setters
-
Iran targets Gulf energy sites after gas field strike
-
Music popstar will.i.am meshes AI and 'micromobility'
-
US Fed Chair says 'no intention' of leaving board while probe ongoing
-
Iran targets Gulf energy sites after intel chief killed
-
Cesar Chavez, icon of US labor movement, accused of serial sex abuse: report
-
Iran suffers new blow as Israel kills intel chief
-
Slovakia curbs diesel sales, ups prices for foreigners
-
US Fed holds rates unchanged over 'uncertain' Iran war implications
-
Billionaire Dyson buys 50 percent stake in Bath rugby
-
The platypus is even weirder than thought, scientists discover
-
How many cargo ships are passing Hormuz strait?
-
Oil surges as Iran gas facilities hit, stocks slide
-
Chilean GDP beats 2025 forecast despite mining dip
-
Storms, warm seas drove sudden drop in Antarctic ice: study
-
Global music market grows, calls for AI compensation: industry body
-
Belgian court suspends TotalEnergies climate trial
-
Troubled waters: Thai fishermen marooned by rising fuel costs
-
Nigerian president meets royals on 'historic' UK state visit
-
Why convoys cannot fully protect oil tankers from Iran attacks
-
Oil wavers, stocks rise as attention turns to US Fed
-
China tech giant Tencent bets on AI agents
-
Israelis shelter with pets from threat of Iran missiles
-
Deadly strikes across Mideast as Iran vows revenge on slain security chief
-
Brussels to unveil 'EU Inc' pan-European company status
-
Brazil starts to restrict minors' access to social media
-
US Fed expected to hold rates steady as Iran war's shockwaves ripple
-
Oscars audience drops, viewing figures show
-
Affiliate of Pacific Avenue Capital Partners Completes Acquisition of Care.com from IAC
-
Nvidia says restarting production of China-bound chips
-
US airlines still see strong demand as jet fuel worries loom
-
Milei blasts Iran on anniversary of attack on Israeli embassy
-
Leftist New York mayor under pressure on Irish unity question
-
Iran vets friendly ships for Hormuz passage: trackers
-
Ships in Gulf risk shortages on board, industry warns
-
New particle discovered by Large Hadron Collider
-
US Fed expected to keep rates steady as Iran war impact looms
-
Kerr 'frustrated' at six-figure sum owed to him by Johnson's failed Grand Slam Track
-
Oil prices climb as fresh strikes target infrastructure
-
Belgian diplomat ordered to stand trial over 1961 Congo leader murder
-
War threatens Gulf's dugongs, turtles and birds
-
Germany targets oil firms to prevent wartime price gouging
Adding peanuts to young children's diet can help avoid allergy: study
Including peanuts in children's diets early in life could help stave off allergies against the legume, which can be fatal and affect swathes of youngsters globally, according to a new study Friday.
Researchers found that introducing peanut products to babies and infants, and gradually increasing exposure, led to greater tolerance for the common allergen.
The peer-reviewed study, published in The Lancet, involved 146 peanut-allergic children aged between zero and three over two-and-a-half years.
Of the group, 96 were given peanut protein powder every day, with the dose increasing progressively to the equivalent of six peanuts. The other children received a placebo of oat flour.
Twenty of the children who received peanut powder showed allergy remission, meaning no allergic reaction occurred six months after the therapy ended.
One child in the placebo group showed remission.
Six months after the treatment, the children in remission could tolerate a dose equivalent to 16 peanuts.
An additional 20 children who received peanut powder were considered 'desensitised', meaning they had a higher allergic threshold but were not considered in remission.
These children could tolerate a dose equivalent to between six and 12 peanuts six months after the treatment ended.
The youngest children in the study experienced remission the most often, and the best results were in those under 12 months.
"Very early interventions may provide the best opportunity to achieve remission", said co-author Stacie Jones.
- 'Considerable burden' -
Peanut allergies affect two percent of children in Western countries, according to the study, and can last a lifetime.
Affected children must avoid eating peanuts and have self-injectable adrenaline available to fight allergic shocks, which can be fatal if they are accidentally exposed.
Exposure can even occur when a child hugs someone who has just consumed peanuts.
"There are no treatment options, resulting in a considerable burden on allergic children and their caregivers to avoid accidental exposure," said co-author Wesley Burks.
"In severe cases, this can restrict peanut-allergic children's freedoms, particularly when it comes to navigating daycare or schools and public spaces where access to a safe diet is in jeopardy," he added.
Previous studies have produced similar results but the length of the latest studies makes it unique.
Although it provided important results, it may not reflect the behaviour of the children's bodies in real-world conditions.
The study was conducted under close medical supervision, and adrenaline injections were administered on 21 children during the trial.
L.Peeters--CPN